Aumovio’s Latest Market Movements and Contextual Peer Performance
Aumovio SE (ticker AMV0.DE) experienced a modest uptick of 1.96 % during the 24‑hour trading window concluding at 03:46 PM Central Europe on Wednesday, 21 October 2026. At the time of writing, a single share traded at approximately EUR 36.05 on the most widely used German exchanges. The company’s market capitalisation stood at EUR 3.5 bn with a circulating supply of 100.1 million shares, and roughly EUR 4.9 million worth of shares were exchanged in the preceding 24 hours.
Aumovio’s share price has risen by 2.82 % since the end of September, suggesting a gradual, rather than dramatic, upward trajectory. The 200‑day simple moving average (SMA) is currently at EUR 37.96, indicating that the present level of trading is slightly below the long‑term trend. Over the past year, the stock reached a high of EUR 47.02 on 12 January 2026 and a low of EUR 32.44 on 30 March 2026, framing its 52‑week volatility range.
Market Reaction to Recent Short‑Position Disclosures
Aumovio’s shares were accompanied by a series of short‑position filings from Marshall Wace LLP, disclosed in the Bundesanzeiger. The reports reveal that short sellers held just under 1 % of the company’s issued capital at the close of August, increasing to roughly 0.6 % by mid‑September. Despite this growing short exposure, the market reaction has been muted. The broader MDAX index declined during the day, yet Aumovio’s movement remained largely independent, reflecting a cautious stance among investors amid weak index momentum and the absence of significant corporate announcements from the automaker itself.
Peer Performance in the Past 24 Hours
| Ticker | Last Close | % Change | Current Price | Market Cap | P/E | Notable Recent Activity |
|---|---|---|---|---|---|---|
| 1&1 (1U1.DE) | -0.21 % | EUR 23.85 | EUR 4.2 bn | 34.88 | Flat SDAX; no major earnings | |
| Puma (PUM.DE) | -0.24 % | EUR 25.33 | EUR 3.6 bn | Under 1 % short‑sale filings | ||
| Schott Pharma & (1SXP.DE) | +1.96 % | EUR 26.00 | EUR 3.9 bn | 24.39 | Preparing for Indian IPO | |
| Dmg Mori (GIL.DE) | 0 % | EUR 47.10 | EUR 3.7 bn | 51.66 | No significant events | |
| AUTO1 Group (AG1.DE) | +3.22 % | EUR 18.26 | EUR 4.1 bn | 46.04 | Multiple short‑position filings |
Schott Pharma & has attracted particular interest with its announcement of an impending initial public offering in India, targeting a raise of approximately USD 400 million. This move aligns with a broader trend of German subsidiaries seeking capital in emerging markets.
In contrast, AUTO1 Group SE’s share price benefited from a 3.22 % rise, even as institutional short positions—disclosed in the Bundesanzeiger—continue to persist. The lack of substantive corporate developments suggests that the price movement is driven more by short‑covering activity than by fundamental factors.
Takeaway
Aumovio’s modest price appreciation, coupled with a slowly increasing short‑position exposure, paints a picture of cautious optimism. While the automaker’s share price remains below its 200‑day SMA, the 52‑week high remains within reach. Investors observing Aumovio should therefore monitor upcoming corporate disclosures and short‑position trends closely, as these elements are likely to influence the stock’s trajectory more than the broader MDAX movements.
